-+ 0.00%
-+ 0.00%
-+ 0.00%

VITTORIA BIOTHERAPEUTICS ANNOUNCES FDA RMAT AND ORPHAN DRUG DESIGNATIONS FOR SENZA5 CART5 (VIPER-101) IN T-CELL LYMPHOMA

Reuters·11/10/2026 13:31:23

Please log in to view news